×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CABA – cabaletta bio, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CABA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/30
07:12 pm
caba
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
Low
Report
What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]
1/27
11:07 am
caba
Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
Low
Report
Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
1/12
08:27 am
caba
Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]
Medium
Report
Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]
1/12
08:00 am
caba
Cabaletta Bio Announces 2026 Strategic Priorities
Medium
Report
Cabaletta Bio Announces 2026 Strategic Priorities
1/12
07:30 am
caba
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
Medium
Report
IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated Platforms
12/15
07:15 am
caba
Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? [Yahoo! Finance]
Low
Report
Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? [Yahoo! Finance]
11/10
07:59 am
caba
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/10
07:55 am
caba
Cabaletta Bio GAAP EPS of -$0.44 beats by $0.04 [Seeking Alpha]
Medium
Report
Cabaletta Bio GAAP EPS of -$0.44 beats by $0.04 [Seeking Alpha]
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/21
06:57 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Chang David J.
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Chang David J.
1/21
06:56 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Tomasello Shawn
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Tomasello Shawn
1/21
06:56 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Binder Gwendolyn
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Binder Gwendolyn
1/21
06:55 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Bollard Catherine
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Bollard Catherine
1/21
06:55 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Gavel Steve
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Gavel Steve
1/21
06:54 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Nichtberger Steven
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Nichtberger Steven
1/21
06:54 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Simon Mark
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Simon Mark
1/21
06:53 pm
caba
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Gerard Michael
High
Report
Form 4 Cabaletta Bio, Inc. For: Jan 21 Filed by: Gerard Michael
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/19
Cabaletta Bio (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at Cowen Inc.
28.4%
2/14 Form SC 13G/A Cabaletta Bio, Inc. Filed by: Cormorant Asset Management, LP 17.0%
1/29 Form 8-K Cabaletta Bio, Inc. For: Jan 29 13.4%
10/24 Form S-1MEF Cabaletta Bio, Inc. 11.1%
3/3 Form 4 Cabaletta Bio, Inc. For: Mar 01 Filed by: Marda Anup 5.9%
3/30 Form 10-K Cabaletta Bio, Inc. For: Dec 31 4.0%
10/28 Form 4 Cabaletta Bio, Inc. For: Oct 24 Filed by: Chang David J. 2.5%
4/16 Cabaletta Bio (NASDAQ: CABA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.4%
10/31 Form 4 Cabaletta Bio, Inc. For: Oct 29 Filed by: 5AM Partners V, LLC 2.4%
2/13 Form SC 13G/A Cabaletta Bio, Inc. Filed by: Flynn James E 1.5%
2/14 Form SC 13G/A Cabaletta Bio, Inc. Filed by: Cormorant Asset Management, LP 17.0%
1/29 Form 8-K Cabaletta Bio, Inc. For: Jan 29 13.4%
10/24 Form S-1MEF Cabaletta Bio, Inc. 11.1%
3/3 Form 4 Cabaletta Bio, Inc. For: Mar 01 Filed by: Marda Anup 5.9%
3/30 Form 10-K Cabaletta Bio, Inc. For: Dec 31 4.0%
10/28 Form 4 Cabaletta Bio, Inc. For: Oct 24 Filed by: Chang David J. 2.5%
4/16 Cabaletta Bio (NASDAQ: CABA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.4%
10/31 Form 4 Cabaletta Bio, Inc. For: Oct 29 Filed by: 5AM Partners V, LLC 2.4%
2/13 Form SC 13G/A Cabaletta Bio, Inc. Filed by: Flynn James E 1.5%
TOP News Decliners
12/5
Form 10-Q Cabaletta Bio, Inc. For: Sep 30
-16.0%
11/12 Form SC 13D Cabaletta Bio, Inc. Filed by: 5AM Ventures V, L.P. -12.0%
3/5 Cabaletta Bio (NASDAQ: CABA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.7%
11/22 Form SEC STAFF LETTER Cabaletta Bio, Inc. -4.5%
11/26 Cabaletta Bio to Present at the Evercore ISI 2nd Annual HealthCONx Conference -4.5%
1/10 Form 8-K Cabaletta Bio, Inc. For: Jan 10 -4.5%
4/23 Form DEF 14A Cabaletta Bio, Inc. For: Jun 02 -4.4%
4/15 Cabaletta Bio (NASDAQ: CABA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.25 price target on the stock. -3.6%
10/29 Form 4 Cabaletta Bio, Inc. For: Oct 29 Filed by: Green Jeremy -3.2%
2/20 Form 8-K Cabaletta Bio, Inc. For: Feb 20 -3.0%
11/12 Form SC 13D Cabaletta Bio, Inc. Filed by: 5AM Ventures V, L.P. -12.0%
3/5 Cabaletta Bio (NASDAQ: CABA) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -5.7%
11/22 Form SEC STAFF LETTER Cabaletta Bio, Inc. -4.5%
11/26 Cabaletta Bio to Present at the Evercore ISI 2nd Annual HealthCONx Conference -4.5%
1/10 Form 8-K Cabaletta Bio, Inc. For: Jan 10 -4.5%
4/23 Form DEF 14A Cabaletta Bio, Inc. For: Jun 02 -4.4%
4/15 Cabaletta Bio (NASDAQ: CABA) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.25 price target on the stock. -3.6%
10/29 Form 4 Cabaletta Bio, Inc. For: Oct 29 Filed by: Green Jeremy -3.2%
2/20 Form 8-K Cabaletta Bio, Inc. For: Feb 20 -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: